M&A Deal Summary |
|
|---|---|
| Date | 2024-12-02 |
| Target | Gannet BioChem |
| Sector | Life Science |
| Buyer(s) | Ampersand Capital Partners |
| Sellers(s) | Nektar |
| Deal Type | Divestiture |
SEARCH BY
| Category | Growth Capital Firm |
|---|---|
| Founded | 1988 |
| PE ASSETS | 3.0B USD |
| Size | Large |
| Type | Sector Focused |
Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 84 of 86 |
| Sector: Life Science M&A | 43 of 43 |
| Type: Divestiture M&A Deals | 6 of 6 |
| State: Alabama M&A | 2 of 2 |
| Country: United States M&A | 69 of 70 |
| Year: 2024 M&A | 5 of 5 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-11-06 |
Avid Bioservices
Tustin, California, United States Avid Bioservices is a CDMO focused on development and CGMP manufacturing of biologics. The Company provides a comprehensive range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. Avid Bioservices is based in Tustin, California. |
Buy | $1.1B |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-04-17 |
Lexington Medical
Bedford, Massachusetts, United States Lexington Medical is a minimally invasive surgical stapling solutions provider, using its AEON Endostapler sets the standard for precision, performance, and clinical outcomes. Rooted in an engineering-driven and talent-dense, collaborative culture, it drives continuous innovation through U.S.-based design and manufacturing, working closely with leading surgeons to enhance patient outcomes. Lexington Medical was formed in 2013 and is based in Bedford, Massachusetts. |
Buy | - |
| Category | Company |
|---|---|
| Founded | 1990 |
| Sector | Life Science |
| Employees | 137 |
| Revenue | 98M USD (2024) |
Nektar is a clinical-stage biopharmaceutical company developing a pipeline of drug candidates that utilize its PEGylation and polymer conjugate technology platforms, which are designed to improve the benefits of drugs for patients. Nektar was founded in 1990 and is based in San Francisco, California.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Life Science M&A | 2 of 2 |
| Type: Divestiture M&A Deals | 2 of 2 |
| State: Alabama M&A | 2 of 2 |
| Country: United States M&A | 2 of 2 |
| Year: 2024 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-11-04 |
Nektar - Commercial PEGylation Reagent Manufacturing Business
Huntsville, Alabama, United States Nektar's Commercial PEGylation Reagent Manufacturing Business site is a 124,000-square-foot, commercial-scale specialized manufacturing facility. Nektar's Commercial PEGylation Reagent Manufacturing Business is based in Huntsville, Alabama. |
Sell | $90M |
